High blood pressure drug trial halted after just one patient
Disease control
Terminated
This was a very early Phase 1 study testing a single injection of ART101 in people with high blood pressure. The trial was stopped after only 1 participant was enrolled, so no meaningful results are available. The goal was to check safety and how the drug moves through the body.
Phase: PHASE1 • Sponsor: Arnatar Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC